Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder
About this trial
This is an interventional treatment trial for Schizophrenia and Disorders With Psychotic Features focused on measuring tobacco
Eligibility Criteria
Inclusion Criteria: Diagnosis of schizophrenia or schizoaffective disorder, smoke 20-50 cpd, clinically stable on antipsychotic and antidepressant medications Exclusion Criteria: Pregnant/nursing women, seizure disorder, lowered seizure threshold due to other medical conditions, positive urine drug screen positive breath alcohol test, past 2 weeks use of MAO inhibitors, any form of bupropion, cimetidine, phenobarbital, phenytoin, DA agonists, anorectics, stimulants
Sites / Locations
- Brown University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
1
2
3
4
Contingent reinforcement plus bupropion
Contingent reinforcement plus placebo
Non-contingent reinforcement plus bupropion
Non-contingent reinforcement plus placebo